CTRI/2022/02/040013
Not Yet Recruiting
N/A
Assessment of Potential Drug-Drug Interactions (PDDIs) with IntegraseStrand Transfer Inhibitors (INSTI)-based Antiretroviral Therapy (ART) in People Living with HIV(PLWHIV): A cross-sectional study.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Sponsor
- Manipal Academy of Higher Education
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •HIV seropositive patients (HIV\-SPP) of either sex on INSTI\-based and other ART therapies,
- •from both in\-patient and out\-patient departments of the study center.
Exclusion Criteria
- •1\. HIV\-SPP who refused ART treatment and did not consent to participate in the study.
- •2\. HIV\-SPP taking only herbal medicines and medications belonging to Ayurvedic, Homeopathic,
- •Siddha, and Unani treatments.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
PotentialDrug-Drug Interactions in Patients AttendingMedicine OPD in a Tertiary Care HospitalHealth Condition 1: Z922- Personal history of drug therapyCTRI/2024/07/071259R G Kar Medical College and Hospital
Not Yet Recruiting
N/A
Analysis of possible interactions between different drugs in older adult patients with chronic kidney diseaseCTRI/2024/08/072194Dr.Akshay Balakrishna
Not Yet Recruiting
N/A
A SEARCH TO IDENTIFY ANY DRUG-DRUG INTERACTION AMONG PSYCHIATRY INPATIENTS IN A TERTIARY HEALTHCARE CENTREHealth Condition 1: F068- Other specified mental disorders due to known physiological conditionCTRI/2022/11/047051il
Recruiting
N/A
Assessment of Adverse drug reactions, drug-drug Interactions and medication adherence outcomes among elderly HIV seropositive patients in comparison with young HIV seropositive patients undergoing highly active antiretroviral therapy.Health Condition 1: null- HIV seropositive patientsCTRI/2018/01/011169Kasturba medical college Kasturba Hospital
Completed
Phase 1
A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral DrugsHealthyNCT03537404R-Pharm36